Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,215,446 papers from all fields of science
Search
Sign In
Create Free Account
interferon beta-1b 0.3 MG Injection [Betaseron]
Known as:
INTERFERON BETA-1B 0.3MG/VIL (BETASERON)
, INTERFERON BETA-1B,RECOMBINANT 0.3MG/VIL (BETASERON)
, Betaseron 0.3 MG Injection
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Albumin Human, USP
Betaseron
Drug Allergy
Injection
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors
D. Barone
,
B. Singer
,
L. Merkov
,
M. Rametta
,
G. Suárez
Neurological Therapeutics
2016
Corpus ID: 27037949
IntroductionPatients with multiple sclerosis (MS) generally undergo long-term treatment with disease-modifying therapies (DMTs…
Expand
Highly Cited
2013
Highly Cited
2013
Characterization and quantitation of aggregates and particles in interferon-β products: potential links between product quality attributes and immunogenicity.
James G Barnard
,
Ken Babcock
,
J. Carpenter
Journal of Pharmacy and Science
2013
Corpus ID: 33104173
Interferon-β (IFN-β) products have been used for many years in the treatment of multiple sclerosis and include recombinant IFN…
Expand
2012
2012
Spotlight on Interferon-β-1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
P. L. McCormack
,
L. Scott
BioDrugs
2012
Corpus ID: 30256113
Interferon-β-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human interferon-β approved for high-frequency…
Expand
2011
2011
Evaluation of soluble HLA-G as a biomarker for multiple sclerosis
A. Waschbisch
,
R. Sandbrink
,
+4 authors
H. Wiendl
Neurology
2011
Corpus ID: 207119878
Human leukocyte antigen G (HLA-G) is a nonclassical HLA class I antigen that stands out for its immune regulatory properties…
Expand
2011
2011
Dianas farmacológicas en la esclerosis múltiple
G. M. Varo-Sánchez
,
M. D. Cuenca-López
,
O. Fernández-Fernández
,
J. Jordán
2011
Corpus ID: 68115479
La esclerosis multiple es la enfermedad inflamatoria, desmielinizante y neurodegenerativa cronica mas frecuente en jovenes…
Expand
Highly Cited
2005
Highly Cited
2005
Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients
B. Weinstock-Guttman
,
M. Baier
,
+11 authors
R. Rudick
2005
Corpus ID: 14491926
2004
2004
Interferon-β-1b
Paul L. McCormack
,
L. Scott
2004
Corpus ID: 209142873
SummaryAbstractInterferon-β-1b (Betaseron®, Betaferon®) is a non-glycosylated recombinant human interferon-β approved for high…
Expand
Review
2004
Review
2004
The pros and cons of early treatment of relapsing forms of multiple sclerosis
X. Montalban
Journal of Neurology
2004
Corpus ID: 22352550
Abstract.Cerebral axonal damage and brain atrophy begin at the earliest stages of multiple sclerosis (MS). Progressive neuronal…
Expand
Review
2004
Review
2004
The Official Publication of the Consortium of Multiple Sclerosis Centers and Rehabilitation in Multiple Sclerosis MSInternationalJournal of CARE
Director
,
E. Rosen
,
Jane Faulkner
,
Regina Scaringella
,
Bruce D. Williams
2004
Corpus ID: 5447776
s may be submitted to either the general meeting, the International Committee on Databases in MS (ICODIMS) special session (for…
Expand
1986
1986
The isolation of human beta-interferon receptor by wheat germ lectin affinity and immunosorbent column chromatographies.
Z. Zhang
,
A. Fournier
,
Y. Tan
Journal of Biological Chemistry
1986
Corpus ID: 9284257
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE